Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Viatris

Close the RMT Transactions combining the Upjohn Business with Mylan

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
29 May 2020
Due
31 Dec 2020
Delivered
16 Nov 2020
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The RMT Transactions are expected to close in the second half of 2020, subject to approval by Mylan shareholders”
  • SourceViatris Form 8-K press release, 2020-05-29
  • FilingSEC filing index
  • Deadline as statedin the second half of 2020
  • Deadline used31 Dec 2020, the last day of the stated period
  • TypeTransaction
  • Permanent referenceKI-C-2020-VTRS-006561
    Cite as https://keptindex.org/c/KI-C-2020-VTRS-006561/ — this address never changes.

What we found

Evidence strength A What the grades mean

Later filings state the Mylan and Upjohn Reverse Morris Trust combination formed Viatris on November 16, 2020, within the second-half 2020 deadline.

  • A
    Viatris 10-K filed 2021-03-01 Regulatory filing · published 1 Mar 2021 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint b83f3e965f28
    “Viatris Inc. was formed in November 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer (“the Combination”).” ✓ confirmed on the page
  • A
    Viatris 10-Q filed 2021-05-10 Regulatory filing · published 10 May 2021 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 2031649b8be4
    “CombinationRefers to Mylan combining with Pfizer's Upjohn Business in a Reverse Morris Trust transaction to form Viatris on November 16, 2020” ✓ confirmed on the page
  • A
    Viatris 10-Q filed 2021-05-10 Regulatory filing · published 10 May 2021 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 2031649b8be4
    “Viatris applied purchase accounting to the acquired assets and assumed liabilities of the Upjohn Business as of November 16, 2020.” ✓ confirmed on the page

Market reaction: the shares moved -6.8% against the S&P 500 over the three sessions around the disclosure (26 Feb 2021 to 3 Mar 2021). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Transaction other
Indicative materiality
Medium rules
Action
Close
Deliverable
Combination of the Upjohn Business and Mylan (Viatris)
Language
Expected (“expects”, “plans”)
In the company’s control
Low
Specificity
Medium
Conditional
Yes: subject to approval by Mylan shareholders; satisfaction of other customary closing conditions, including receipt of regulatory approvals
Depends on
Shareholder, Regulatory, Counterparty

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Viatris? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2020-VTRS-006561 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.